Skip to content
Search

Latest Stories

MHRA drug alert for Ibuprofen 400 mg tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for Ibuprofen 400 mg tablets.

Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd have informed the government agency that Patient Information Leaflet (PIL) within their packs of certain pharmacy (P) batches are incorrect.


The PIL in these batches includes incorrect dosing instructions in Section 3, How to take Ibuprofen. The leaflet incorrectly states that ‘The maximum daily dose should not exceed 6 [six] tablets (2400 mg)'.

The correct statement is: ‘The maximum daily dose should not be more than 3 tablets (1200 mg)'.

“This dosing regimen should only be given to patients who are under the supervision of their GP or healthcare prescriber and have been prescribed Ibuprofen 400mg Tablets. The outer carton contains the correct P indications and posology,” the MHRA statement read.

Pharmacists are asked to check the Marketing Authorisation Holder and the batch number while dispensing or providing the product over the counter and ensure that patients are aware of the correct dosage instructions and maximum daily dose as stated on the carton labelling.

MHRA further suggested to dispense these batches against a prescription rather than sold over the counter to safeguard patients from taking a prescription-only dose.

Product details:

Crescent Pharma Ltd

Ibuprofen 400mg Tablets (Almus Livery) PL 20416/0089

Batch NumberExpiry DatePack SizeFirst Distributed
DO3210N, DO3410N, DO3510N09.20228411 Jun 19
DO3310N 09.20228407 Aug 19
DO3610N10.20228418 Jul 19
DO3710N, DO3811N10.20228412 Mar 19
DO3911N10.20228419 Jul 19
DO4212N11.20228419 Jul 19
DO3110N09.20228416 Apr 19
DO1303N02.20228408 Oct 18
DO1003N02.20228412 Jul 18
DO0902N02.20228412 Jul 18

Ibuprofen 400mg Tablets (Crescent Livery) PL 20416/0089

Batch NumberExpiry DatePack SizeFirst Distributed
001205M04.20218408 Aug 19
DO0101O12.20228410 Jan 20
DO0503O02.20238410 Jan 20
DO4312N12.20228425 Nov 2019
DO3010N09.20228411 Dec 2019
DO1705O04.20238407 Oct 2019
DO1605O 04.20238418 Oct 2019
DO1505O 04.20238401 Oct 2019
DO1405O 04.20238401 Oct 2019
DO1305O 04.20238427 Dec 2019
DO1205O 04.20238409 Sep 2019
DO1104O 04.20238427 Dec 2019
DO1004O 03.20238409 Sep 2019
DO0904O03.20238421 Nov 2019
DO0804O03.20238421 Nov 2019
DO0703O03.20238415 Nov 2019
DO0603O02.20238415 Nov 2019
DO0403O02.20238415 Nov 2019

Flamingo Pharma (UK) Ltd

Ibuprofen 400mg Tablets (Flamingo Pharma Livery) PL 43461/0005

Batch NumberExpiry DatePack SizeFirst Distributed
1402177Aug-2324Oct-18
1402268Sep-2348Nov-18
1402278Oct-2324Dec-18
1402308, 1402309, 1402310Nov-2384Dec-18
1402316, 1402317Nov-2384Jan-19
1402318Dec-2324Jan-19
1402337, 1402338Dec-2348Jan-19
1402363, 1402353, 1402354Dec-2348Mar-19
1402352, 1402361, 1402362Dec-2384Mar-19
1402368Jan-2448Mar-19
1402369,1402370Jan-2424Mar-19
1402424Mar-2424Apr-19
1402425Mar-2348Apr-19
1402543, 1402544Mar-2448Jul-19
1402554Jun-2424Jul-19
1402557Jun-2484Aug-19
1402558, 1402559Jun-2448Aug-19
1402622, 1402623Jul-2448Sep-19
1402624, 1402625, 1402628Jul-2424Sep-19
1402670, 1402671, 1402672, 1402673Aug-2424Nov-19
1402674, 1402686, 1402687, 1402688, 1402705Sep-2448Nov-19
1402706Sep-2484Nov-19
1402707, 1402708Oct-2448Dec-19
1402709, 1402710Oct-2484Dec-19
1402711Nov-2484Jan-20
1402837, 1402838Dec-2424Feb-20
1402854Dec-2448Feb-20
1402839, 1402852Dec-2496Feb-20
1402853Dec-2484Feb-20

Ibuprofen 400mg Tablets (TEVA Livery) PL 43461/0005

Batch NumberExpiry DatePack SizeFirst Distributed
1402172, 1402173Jul-2384Sep-18
1402174, 1402175, 1402176, 1402178Aug-2384Oct-18
1402279Nov-2384Dec-18

More For You

Pharmacies NHS weight loss jabs

Pharmacies already sell the medication as a private service

Pic credit: iStock

Pharmacies in line to roll out NHS weight loss jabs

Pharmacies are “best placed” to deliver a planned rollout off greater access to weight loss jabs which could benefit 3.4 million people in England.

Reports today claim the government is looking at trials that would see the medication made available following a short, over-the-counter consultation for the price of an NHS prescription.

Keep ReadingShow less
Numark welcomes hub and spoke change, but calls for clear economic model

The H Human Medicines Regulations amendments will come into force on 1 October 2025.

Image credit: Getty Images

Hub and spoke dispensing between separate pharmacy businesses to begin in October

Community Pharmacy England (CPE) has confirmed that the government has laid amendments to the Human Medicines Regulations 2012 (HMR) in Parliament, marking a crucial step towards enabling hub and spoke dispensing between separate community pharmacy businesses.

The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 are set to come into force on 1 October 2025.

Keep ReadingShow less
Lib Dems condemn rising unsolved crimes, say shoplifting and burglary ‘effectively decriminalised’

Leicestershire police recorded the lowest charge rate for shoplifting in the country.

Gettyimages

Shoplifting and burglary ‘effectively decriminalised’, warn Lib Dems as unsolved crimes soar

The Liberal Democrats have raised alarm over what they describe as the “decriminalisation” of burglary and shoplifting, as new data reveals that the vast majority of such offences across Britain are going unsolved.

Figures revealed by the House of Commons Library research, commissioned by the party, showed that only 5.25 per cent of shoplifting offences in London last year led to a suspect being charged.

Keep ReadingShow less
RPS and HEIW extend independent prescribing learning programme for pharmacists in Wales

The programme is designed to support pharmacists delivering the Pharmacy Independent Prescribing Service in Wales.

gettyimages

Independent prescribing learning programme for pharmacists in Wales extended till 2028

The Royal Pharmaceutical Society (RPS) and Health Education and Improvement Wales (HEIW) have announced a three-year extension of their successful learning programme designed to support pharmacists delivering the Pharmacy Independent Prescribing Service (PIPS) in Wales.

Originally launched in 2024, the programme equips pharmacists with the essential knowledge, skills, and confidence needed to provide excellent patient care as independent prescribers.

Keep ReadingShow less
NPA’s first female vice-chair Sukhi Basra

NPA’s first female vice-chair Sukhi Basra

Sukhi Basra

NPA’s first female vice-chair vows to “open doors” for next generation

The National Pharmacy Association’s (NPA) new vice-chair has vowed to be an “advocate” for community pharmacy and see the sector get the recognition it deserves.

Sukhi Basra created history this week when she became the first female vice-chair of the NPA and she is determined to ensure she makes a lasting change in her new role.

Keep ReadingShow less